Addus HomeCare (NASDAQ:ADUS) Shares Gap Down to $119.52

Addus HomeCare Co. (NASDAQ:ADUS)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $119.52, but opened at $112.49. Addus HomeCare shares last traded at $112.18, with a volume of 144,447 shares trading hands.

Analysts Set New Price Targets

A number of research analysts have issued reports on ADUS shares. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 21st. Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a research note on Tuesday, April 23rd. Oppenheimer upped their price objective on Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. TD Cowen upped their price objective on Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Finally, Bank of America upped their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. One analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $113.43.

Addus HomeCare Trading Down 5.7 %

The stock has a market capitalization of $1.85 billion, a P/E ratio of 27.84, a price-to-earnings-growth ratio of 2.30 and a beta of 1.02. The stock has a 50-day moving average price of $108.99 and a two-hundred day moving average price of $99.65. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.84 earnings per share. On average, research analysts forecast that Addus HomeCare Co. will post 4.36 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Hedge funds have recently bought and sold shares of the stock. Principal Securities Inc. bought a new stake in Addus HomeCare during the fourth quarter valued at about $26,000. GAMMA Investing LLC bought a new position in shares of Addus HomeCare in the fourth quarter worth about $34,000. EntryPoint Capital LLC bought a new position in shares of Addus HomeCare in the first quarter worth about $44,000. Assetmark Inc. boosted its stake in shares of Addus HomeCare by 33.3% in the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of Addus HomeCare in the fourth quarter worth about $214,000. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.